Ergocalciferol and Methylphenidate hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Methylphenidate hydrochloride (methylphenidate hydrochloride). Common drug interactions include metabolic disorder among females and blood pressure fluctuation among males.

The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Methylphenidate hydrochloride. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

What is Methylphenidate hydrochloride?

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,822 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.

On Jul, 07, 2026

39 people who take Ergocalciferol and Methylphenidate hydrochloride together, and have interactions are studied.

Ergocalciferol and Methylphenidate hydrochloride drug interactions.

What are the common drug interactions of Ergocalciferol and Methylphenidate Hydrochloride, by gender? *:

female:

Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
Muscle spasms (muscle contraction)
Nephrolithiasis (calculi in the kidneys)
Neuralgia (pain in one or more nerves)
Neuropathy peripheral (surface nerve damage)
Oedema peripheral (superficial swelling)
Oropharyngeal discomfort (pain or irritation of oropharynx)
Pain in extremity
Pleural effusion (water on the lungs)
Presyncope

male:

Blood pressure fluctuation
Heart rate decreased
Adenovirus infection
Anal abscess
Arthralgia (joint pain)
Cardiac arrest
Chills (felling of cold)
Colitis (inflammation of colon)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Death

What are the common drug interactions of Ergocalciferol and Methylphenidate Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain
Adenovirus infection
Anal abscess
Cardiac arrest
Chills (felling of cold)
Colitis (inflammation of colon)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Death
Decreased appetite
Dehydration (dryness resulting from the removal of water)

20-29:

Pain
Dizziness
Drug intolerance (drug sensitivity)
Nausea (feeling of having an urge to vomit)

30-39:

Acne (skin problems that cause pimples)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Back pain
Blood pressure increased
Confusional state
Dizziness
Headache (pain in head)
Hemiparesis (weakness on one side of the body)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)

40-49:

Cardiomegaly (increased size of heart than normal)
Depression
Pulmonary hypertension (increase in blood pressure in the lung artery)
Tricuspid valve incompetence (inefficient heart valve)
Dyskinesia (abnormality or impairment of voluntary movement)
Lacrimation increased
Nausea (feeling of having an urge to vomit)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Appendicitis (inflammation of the appendix)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

50-59:

Viral infection
Body temperature fluctuation
Body temperature decreased
Nasopharyngitis (inflammation of the nasopharynx)
Blood pressure increased
Heart rate increased
Malaise (a feeling of general discomfort or uneasiness)
Arthralgia (joint pain)
Oedema peripheral (superficial swelling)
Blood pressure fluctuation

60+:

Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Sinusitis (inflammation of sinus)
Abnormal faeces (abnormal stool)
Bacterial test positive
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Oropharyngeal discomfort (pain or irritation of oropharynx)
Pulmonary function test decreased

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 33.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 23.08%
Sleep Disorder: 7 people, 17.95%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 15.38%
Drowsiness: 6 people, 15.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 10.26%
Infection: 3 people, 7.69%
High Blood Pressure: 3 people, 7.69%
Stress And Anxiety: 2 people, 5.13%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Ergocalciferol and Methylphenidate hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously